Every 8-K that Quaker Houghton (KWR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow KWR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KWR filings page.
Quaker Chemical Corporation (KWR) disclosed that, effective September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer. The company states that his departure is not related to any disagreement with Quaker Houghton.
Mr. Bijlani’s separation will be treated as a termination without cause for purposes of all applicable plan benefits and his employment agreement dated September 28, 2017, effective August 1, 2019. Subject to executing a customary release of claims, he will receive severance payments and benefits consistent with those described in Quaker Chemical’s Proxy Statement filed on March 31, 2026.
Quaker Houghton reported strong second-quarter 2026 results, with net sales of $532.6 million, up 10% year over year, driven by 7% higher volumes, 2% favorable foreign exchange and 1% price/mix. The company generated net income of $26.8 million, or $1.55 diluted EPS, versus a net loss of $66.6 million, or $(3.78) per share, a year earlier. On a non-GAAP basis, net income was $37.9 million and non-GAAP diluted EPS $2.19, a 28% increase. Adjusted EBITDA rose to $85.2 million, up about 13%, with a 16.0% margin.
All regions contributed to growth: Americas sales rose 7%, EMEA 13%, and Asia/Pacific 12%, with segment operating earnings higher in EMEA and Asia/Pacific. For the six months, operating cash flow was $33.2 million. As of June 30, 2026, the company had $876.1 million of gross debt, cash of $155.1 million, and net debt of approximately $721.0 million, equating to a 2.3x net debt to trailing twelve months adjusted EBITDA leverage ratio. Quaker Houghton increased its quarterly dividend by about 4.3%, repurchased 170,568 shares for $24.2 million, and authorized a new $250 million share repurchase program. Management expects stable demand with flat to slightly positive end markets and targets gross margins within its desired range, supporting meaningful revenue and adjusted EBITDA growth over 2026.
Quaker Chemical Corporation reports a leadership change in its finance organization. On June 30, 2026, Steven Dassing resigned as Vice President, Corporate Controller and Principal Accounting Officer, effective July 22, 2026, to pursue another career opportunity, and the company states the resignation does not stem from any dispute or disagreement.
After his resignation becomes effective, Executive Vice President and Chief Financial Officer Mr. Coler, age 53, will also serve as Principal Accounting Officer. The company notes there are no new compensatory arrangements for him in this added role and no family relationships or related-party transactions requiring disclosure.
Quaker Chemical Corporation announced that long-time director and Chairman Michael F. Barry will retire from the Board after the May 13, 2026 meeting. The Board reduced its size from eleven to ten directors and elected independent director Mark A. Douglas as the new Chairman, eliminating the Lead Director role. Shareholders elected three directors for terms ending in 2029, approved on an advisory basis the compensation of named executive officers, and ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026. The company also issued a press release honoring Mr. Barry’s contributions and outlining related governance changes.
Quaker Houghton reported stronger first-quarter 2026 results with higher sales and profit. Net sales were $480.5 million, up 8% from $442.9 million a year earlier, helped by 3% higher volumes, 4% growth from acquisitions and favorable currency, partly offset by lower pricing and mix.
Net income rose to $19.7 million, or $1.13 per diluted share, compared with $12.9 million, or $0.73 per share, while non-GAAP net income was $28.4 million and non-GAAP diluted EPS was $1.63, slightly above $1.58 last year. Adjusted EBITDA increased 5% to $72.5 million.
Asia/Pacific led growth with 25% higher sales, EMEA grew 10% and Americas was flat year over year. Operating cash flow improved to $3.8 million from a $3.1 million outflow. The company ended March 31, 2026 with $875.0 million of gross debt, $169.7 million of cash and a net debt-to-trailing adjusted EBITDA ratio of about 2.3x.
Quaker Houghton amended its credit agreement after quarter-end, extending the nearest maturity to 2031 and increasing available credit, and launched a global transformation and cost program targeting $20 million to $30 million of annualized savings by 2028, with a $10 million run-rate goal by the end of 2026.
Quaker Houghton entered into an amended senior secured credit agreement that refinances its existing facilities, extends debt maturities and increases available borrowing capacity. The new package includes a $550 million U.S. dollar term loan, a $250 million-equivalent euro term loan and an $800 million revolving credit facility, all maturing in 2031. Proceeds repaid the prior credit agreement and support working capital, strategic growth and other capital allocation plans. The facility is secured by first‑priority liens on substantially all assets of the company and certain subsidiaries, and includes leverage and interest coverage covenants plus limits on additional debt, acquisitions, dividends, buybacks and other restricted payments.
Quaker Chemical Corporation, also known as Quaker Houghton, reported that effective March 9, 2026, Jeffrey Fleck no longer serves as Senior Vice President and Chief Global Operations Officer.
The company states that his departure is not due to any disagreement with the company. His separation is classified as an involuntary termination without cause for purposes of plan benefits and contractual entitlements under his January 23, 2023 employment agreement. Subject to signing a customary release of claims, he will receive severance payments and benefits consistent with the terms previously described in the company’s March 31, 2025 proxy statement.
Quaker Houghton reported higher fourth-quarter 2025 results, with net sales of $468.5 million, up 6% year over year. GAAP net income rose to $20.7 million, or $1.18 per diluted share, while non-GAAP earnings were $28.9 million, or $1.65 per share.
For full-year 2025, net sales reached $1.89 billion, but the company posted a GAAP net loss of $2.5 million, or $0.14 per share, driven by an $88.8 million impairment and $35.1 million of restructuring charges. Non-GAAP net income was $123.2 million, or $7.02 per share, and adjusted EBITDA was $299.2 million. Quaker Houghton generated $136.5 million of operating cash flow, ended the year with $691.4 million of net debt and a 2.3x leverage ratio, and returned $75.9 million to shareholders through dividends and share repurchases.
Quaker Chemical Corporation reported that it announced results of operations for the third quarter ended September 30, 2025. The company furnished a press release and related supplemental information to summarize its Q3 2025 performance and financial condition.
The materials are provided as Exhibits 99.1 (press release dated October 30, 2025) and 99.2 (supplemental information for the third quarter ended September 30, 2025). These exhibits offer the detailed financial and operating updates for the period.